Last reviewed · How we verify
NCT04833738
Hyaluronic Acid, Corticosteroid and Electrotherapy in Subacromial Impingement Syndrome
NA trial testing Hyaluronic acid in Subacromial Impingement in 90 participants. Completed in 28 May 2014.
10 December 2013
Quick facts
| Lead sponsor | Şeyhmus KAPLAN |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 11 September 2013 |
| Primary completion | 10 December 2013 |
| Estimated completion | 28 May 2014 |
Drugs / interventions tested
- Hyaluronic acid (HYALURONIC ACID) — full drug profile →
- Corticosteroids Triamcinolone Acetonide — full drug profile →
- Electrotherapy
Conditions studied
- Subacromial Impingement — all drugs for Subacromial Impingement →
- Pain, Shoulder — all drugs for Pain, Shoulder →
Sponsor
Şeyhmus KAPLAN — full company profile →
Who can join
Adults 20 to 50, any sex, with Subacromial Impingement or Pain, Shoulder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Electrotherapy, corticosteroid, and hyaluronic acid have been used to treat subacromial impingement syndrome. However, we need to compare treatment options to provide the optimal results. This study aims to compare the effect of hyaluronic acid, corticosteroid, and electrotherapy in subacromial impingement syndrome. Design: Ninety five patients were randomised into three equal groups according to treatment types. Hyaluronic acid (20 mg/2ml, three times one week apart) or corticosteroid (triamcinolone acetonide, 40 mg/ml, single dose) treatments were applied as subacromial injections. Electrotherapy consisted of 14 sessions TENS (20 min.), hotpack (20 min.) and ultrasound (1.5watt/cm2, 1 MHz, 6 min.). Patients were evaluated before treatment, one and four weeks post end of treatment. Visual Analogue Scale (VAS), range of motion (ROM), and Shoulder Disability Questionnaire (SDQ) were used as outcome measures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04833738
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hyaluronic acid
Trials testing the same drug.
- NCT07236632 — Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized S · NA · not yet recruiting
- NCT06437054 — Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss · Phase 1, PHASE2 · not yet recruiting
- NCT07437885 — Effects of the Adjunctive Use of Hyaluronic Acid-based Gel With Coranally Advanced Flap in the Gingival Recession · Phase 1, PHASE2 · completed
- NCT06253975 — Randomized, Controlled, Multicenter Study of Extracellular Vesicles From Human Adipose Tissue Promoting Wound Healing · NA · unknown
- NCT06694532 — EffIcacy Between Arthrocentesis With High Versus Low Molecular Weight Hyaluronic Acid in Treatment of TMJ Disorders · Phase 1, PHASE2 · recruiting
Other Şeyhmus KAPLAN trials
Trials by the same sponsor.
- NCT04838002 — The Effects of Radial and Focused Extracorporeal Shock Wave Therapies on Lateral Epicondylitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04833738 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Şeyhmus KAPLAN
- Last refreshed: 6 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04833738.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing